Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-up of rasagiline treatment in Parkinson's disease (ADAGIO extension)
2009-011541-24Phase 4Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- May 2009
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rasagiline in Parkinson's disease (PD), sponsored by Teva Pharmaceutical Industries Ltd. Started May 2009; status: completed.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2009-011541-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011541-24.